Statins reduce development of acute-on-chronic liver failure in patients with cirrhosis

Abstract

Acute-on-chronic liver failure can be fatal in patients with cirrhosis, but there are no therapies to prevent this. We summarize the @GIJournal Twitter® discussion held on May 8, 2022, during which we discussed the article by Mahmud et al. titled “Statin exposure is associated with reduced development of acute-on-chronic liver failure in a Veterans Affairs cohort”¹. The session was moderated by Dr. Rohit Mehtani (RM [@RohitMehtaniDM]) and the key findings were critically reviewed by Dr. Nadim Mahmud (NM [@nadimmahmud]) and Dr. Vinay Sundaram (VS [@VinaySundaramMD]).